Traws Pharma, Inc.
TRAW
$0.83
-$0.01-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -133.07% | 75.13% | 53.25% | 99.26% | 531.27% |
| Total Depreciation and Amortization | 4,300.00% | 2,100.00% | 650.00% | -75.00% | -75.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.01% | -98.32% | -59.77% | -100.03% | -8,013.51% |
| Change in Net Operating Assets | 741.32% | 281.32% | 93.96% | -10.25% | -359.46% |
| Cash from Operations | 52.62% | 31.73% | 65.05% | 39.31% | -22.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,294.85% | -89.50% | -- | -76.72% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14,492.31% | -99.21% | -- | -77.89% | -- |
| Foreign Exchange rate Adjustments | -134.78% | 100.00% | -- | 1,033.33% | 428.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.28% | -116.32% | 41.96% | -675.81% | -21.89% |